Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2019 Publisher: Bracco U.K. Ltd, Unit 15, Valley Business Centre, Gordon Road, High Wycombe, Buckinghamshire HP13 6EQ, United Kingdom
Iomeron 250, solution for injection.
| Pharmaceutical Form |
|---|
|
Solution for injection. |
Contains 51.03% w/v of iomeprol equivalent to 25% iodine or 250mg iodine/ml.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Iomeprol |
|
| List of Excipients |
|---|
|
Trometamol |
Colourless Type I or Type II glass bottles with rubber/aluminium cap.
Quantities of 20, 30, 50, 75, 100, 150, 200 or 250 ml of solution.
Bracco U.K. Ltd, Unit 15, Valley Business Centre, Gordon Road, High Wycombe, Buckinghamshire HP13 6EQ, United Kingdom
18920/0003
11 December 1992 / 29 December 1998
| Drug | Countries | |
|---|---|---|
| IOMERON | Austria, Brazil, Spain, Finland, France, Hong Kong, Croatia, Ireland, Japan, New Zealand, Poland, Romania, Turkey, United Kingdom |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
